European Journal of Vascular & Endovascular Surgery
Volume 33, Issue 3 , Pages 330-339 , March 2007

Anti-endotoxin Hyperimmune Globulin Attenuates Portal Cytokinaemia, Phagocytic Cell Priming, and Acute Lung Injury after Lower Limb Ischaemia-reperfusion Injury

  • D.W. Harkin

      Affiliations

    • Regional Vascular Surgical Unit, The Royal Victoria Hospital, Grosvenor Road, Belfast BT12 6BJ, Northern Ireland, UK
    • Division of Surgery and Perioperative Care, Queen's University of Belfast, School of Medicine and Dentistry, Grosvenor Road, Belfast BT12 6BJ, Northern Ireland, UK
    • Corresponding Author InformationCorresponding author. Mr D.W. Harkin, Senior Lecturer in Surgery, Division of Surgery & Perioperative Care, Queen's University of Belfast, School of Medicine and Dentistry, Grosvenor Road, Belfast BT12 6BJ, Northern Ireland, UK.
    • ,
  • R. Arnold

      Affiliations

    • Division of Surgery and Perioperative Care, Queen's University of Belfast, School of Medicine and Dentistry, Grosvenor Road, Belfast BT12 6BJ, Northern Ireland, UK
    • ,
  • M. Hoper

      Affiliations

    • Division of Surgery and Perioperative Care, Queen's University of Belfast, School of Medicine and Dentistry, Grosvenor Road, Belfast BT12 6BJ, Northern Ireland, UK

,Accepted 23 October 2006.

References 

  1. Dormandy J, Heeck L, Vig S. Acute limb ischemia. Semin Vasc Surg. 1999;12(2):148–153
  2. Campbell WB, Ridler BM, Szymanska TH. Current management of acute leg ischaemia: results of an audit by the Vascular Surgical Society of Great Britain and Ireland. Br J Surg. 1998;85(11):1498–1503
  3. Adam DJ, Beard JD, Cleveland T, Bell J, Bradbury AW, Forbes JF, et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet. 2005;366(9501):1925–1934
  4. Eliason JL, Wainess RM, Proctor MC, Dimick JB, Cowan JA, Upchurch GR, et al. A national and single institutional experience in the contemporary treatment of acute lower extremity ischemia. Ann Surg. 2003;238(3):382–389
  5. Blaisdell FW. The pathophysiology of skeletal muscle ischemia and the reperfusion syndrome: a review. Cardiovasc Surg. 2002;10(6):620–630
  6. Defraigne JO, Pincemail J. Local and systemic consequences of severe ischemia and reperfusion of the skeletal muscle. Physiopathology and prevention. Acta Chir Belg. 1998;98(4):176–186
  7. Harkin DW, Barros D'Sa AA, McCallion K, Hoper M, Halliday MI, Campbell FC. Circulating neutrophil priming and systemic inflammation in limb ischaemia-reperfusion injury. Int Angiol. 2001;20(1):78–89
  8. Groeneveld AB, Raijmakers PG, Rauwerda JA, Hack CE. The inflammatory response to vascular surgery-associated ischaemia and reperfusion in man: effect on postoperative pulmonary function. Eur J Vasc Endovasc Surg. 1997;14(5):351–359
  9. MacCallum NS, Evans TW. Epidemiology of acute lung injury. Curr Opin Crit Care. 2005;11(1):43–49
  10. Pararajasingam R, Nicholson ML, Bell PR, Sayers RD. Non-cardiogenic pulmonary oedema in vascular surgery. Eur J Vasc Endovasc Surg. 1999;17(2):93–105
  11. Yassin MM, Harkin DW, Barros D'Sa AA, Halliday MI, Rowlands BJ. Lower limb ischemia-reperfusion injury triggers a systemic inflammatory response and multiple organ dysfunction. World J Surg. 2002;26(1):115–121
  12. Edrees WK, Lau LL, Young IS, Smye MG, Gardiner KR, Lee B, et al. The effect of lower limb ischaemia-reperfusion on intestinal permeability and the systemic inflammatory response. Eur J Vasc Endovasc Surg. 2003;25(4):330–335
  13. Roumen RM, Frieling JT, van Tits HW, van der Vliet JA, Goris RJ. Endotoxemia after major vascular operations. J Vasc Surg. 1993;18(5):853–857
  14. Foulds S, Cheshire NJ, Schachter M, Wolfe JH, Mansfield AO. Endotoxin related early neutrophil activation is associated with outcome after thoracoabdominal aortic aneurysm repair. Br J Surg. 1997;84(2):172–177
  15. Santos AA, Wilmore DW. The systemic inflammatory response: perspective of human endotoxemia. Shock. 1996;6(Suppl. 1):S50–S56
  16. Rotstein OD. Pathogenesis of multiple organ dysfunction syndrome: gut origin, protection, and decontamination. Surg Infect (Larchmt). 2000;1(3):217–223
  17. Norwood MG, Bown MJ, Sayers RD. Ischaemia-reperfusion injury and regional inflammatory responses in abdominal aortic aneurysm repair. Eur J Vasc Endovasc Surg. 2004;28(3):234–245
  18. Harkin DW, Barros D'Sa AA, McCallion K, Hoper M, Halliday MI, Campbell FC. Bactericidal/permeability-increasing protein attenuates systemic inflammation and acute lung injury in porcine lower limb ischemia-reperfusion injury. Ann Surg. 2001;234(2):233–244
  19. Downey GP, Fukushima T, Fialkow L, Waddell TK. Intracellular signaling in neutrophil priming and activation. Semin Cell Biol. 1995;6(6):345–356
  20. Soong CV, Blair PH, Halliday MI, McCaigue MD, Campbell GR, Hood JM, et al. Endotoxaemia, the generation of the cytokines and their relationship to intramucosal acidosis of the sigmoid colon in elective abdominal aortic aneurysm repair. Eur J Vasc Surg. 1993;7(5):534–539
  21. Sugita T, Watarida S, Katsuyama K, Nakajima Y, Yamamoto R, Matsuno S, et al. Endotoxemia after elective surgery for abdominal aortic aneurysm and the effect of early oral feeding. J Cardiovasc Surg (Torino). 1998;39(5):547–549
  22. Goldie AS, Fearon KC, Ross JA, Barclay GR, Jackson RE, Grant IS, et al. Natural cytokine antagonists and endogenous antiendotoxin core antibodies in sepsis syndrome. The Sepsis Intervention Group. JAMA. 1995;274(2):172–177
  23. Sautner T, Riegler M, Fugger R. Global goals of oxygen metabolism and intestinal integrity. Crit Care Med. 1999;27(10):2325–2326
  24. Dunn DL. Prevention and treatment of multiple organ dysfunction syndrome: lessons learned and future prospects. Surg Infect (Larchmt). 2000;1(3):227–236
  25. Barclay GR. Endotoxin-core antibodies: time for a reappraisal?. Intensive Care Med. 1999;25(5):427–429
  26. Brown GE, Silver GM, Reiff J, Allen RC, Fink MP. Polymorphonuclear neutrophil chemiluminescence in whole blood from blunt trauma patients with multiple injuries. J Trauma. 1999;46(2):297–305
  27. Nezu Y, Tagawa M, Sakaue Y, Hara Y, Tsuchida S, Ogawa R. Kinetics of endotoxin concentration and tumor necrosis factor-alpha, interleukin-1beta, and interleukin-6 activities in the systemic and portal circulation during small intestinal ischemia and reperfusion in dogs. Am J Vet Res. 2002;63(12):1680–1686
  28. Norwood MG, Bown MJ, Sutton AJ, Nicholson ML, Sayers RD. Interleukin 6 production during abdominal aortic aneurysm repair arises from the gastrointestinal tract and not the legs. Br J Surg. 2004;91(9):1153–1156
  29. Szabo G, Romics L, Frendl G. Liver in sepsis and systemic inflammatory response syndrome. Clin Liver Dis. 2002;6(4):1045–1066x
  30. Biffl WL, Moore EE, Moore FA, Peterson VM. Interleukin-6 in the injured patient. Marker of injury or mediator of inflammation?. Ann Surg. 1996;224(5):647–664
  31. Biffl WL, Moore EE, Moore FA, Carl VS, Kim FJ, Franciose RJ. Interleukin-6 potentiates neutrophil priming with platelet-activating factor. Arch Surg. 1994;129(11):1131–1136
  32. Froon AH, Greve JW, van der Linden CJ, Buurman WA. Increased concentrations of cytokines and adhesion molecules in patients after repair of abdominal aortic aneurysm. Eur J Surg. 1996;162(4):287–296
  33. Allen BS. The role of leukodepletion in limiting ischemia/reperfusion damage in the heart, lung and lower extremity. Perfusion. 2002;(17 Suppl):11–22
  34. Holzheimer RG, Gross J, Schein M. Pro- and anti-inflammatory cytokine-response in abdominal aortic aneurysm repair: a clinical model of ischemia-reperfusion. Shock. 1999;11(5):305–310

 These studies were supported in part by a Wellcome Trust Project Grant, (DWH)

PII: S1078-5884(06)00612-5

doi: 10.1016/j.ejvs.2006.10.024

European Journal of Vascular & Endovascular Surgery
Volume 33, Issue 3 , Pages 330-339 , March 2007

Article Tools

* Image Usage & Resolution